Bharati R Dhruva

Array ( [id] => 7778083 [patent_doc_number] => 20120040829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'BACTERIAL GHOSTS AS CARRIER AND TARGETING VEHICLES' [patent_app_type] => utility [patent_app_number] => 13/282144 [patent_app_country] => US [patent_app_date] => 2011-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5977 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20120040829.pdf [firstpage_image] =>[orig_patent_app_number] => 13282144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10032913 [patent_doc_number] => 09074221 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-07 [patent_title] => 'Homozygous and heterozygous IDH1 gene-defective cell lines derived from human colorectal cells' [patent_app_type] => utility [patent_app_number] => 13/881417 [patent_app_country] => US [patent_app_date] => 2011-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 2586 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13881417 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9173898 [patent_doc_number] => 20130315883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-28 [patent_title] => 'CONTROL OF PATHOGENS AND PARASITES' [patent_app_type] => utility [patent_app_number] => 13/880931 [patent_app_country] => US [patent_app_date] => 2011-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 23386 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13880931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9009936 [patent_doc_number] => 08525237 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-09-03 [patent_title] => 'Electrically conductive polymer nanowires with incorporated viruses' [patent_app_type] => utility [patent_app_number] => 13/251923 [patent_app_country] => US [patent_app_date] => 2011-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 39 [patent_no_of_words] => 8674 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13251923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10318865 [patent_doc_number] => 20150203868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-23 [patent_title] => 'GENE THERAPY METHODS' [patent_app_type] => utility [patent_app_number] => 14/346647 [patent_app_country] => US [patent_app_date] => 2011-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 34754 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14346647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8906786 [patent_doc_number] => 20130174289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-04 [patent_title] => 'Na+/Mg2+ Exchanger' [patent_app_type] => utility [patent_app_number] => 13/823383 [patent_app_country] => US [patent_app_date] => 2011-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11235 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13823383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8928588 [patent_doc_number] => 20130184348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-18 [patent_title] => 'SKIN ACTIVATION BY ACCELERATION OF PDGF-BB ACTIVITY' [patent_app_type] => utility [patent_app_number] => 13/823211 [patent_app_country] => US [patent_app_date] => 2011-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4732 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13823211 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9120759 [patent_doc_number] => 20130287681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-31 [patent_title] => 'SOMATOSTATIN RECEPTOR-BASED CANCER THERAPY' [patent_app_type] => utility [patent_app_number] => 13/821541 [patent_app_country] => US [patent_app_date] => 2011-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 28541 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13821541 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9648632 [patent_doc_number] => 08802643 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2014-08-12 [patent_title] => 'Method for the treatment of malignancies' [patent_app_type] => utility [patent_app_number] => 13/216855 [patent_app_country] => US [patent_app_date] => 2011-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 31 [patent_no_of_words] => 12346 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13216855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9147734 [patent_doc_number] => 20130302257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-14 [patent_title] => 'Compositions and Methods for Delivering Nucleic Acid Molecules and Treating Cancer' [patent_app_type] => utility [patent_app_number] => 13/817054 [patent_app_country] => US [patent_app_date] => 2011-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 32715 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13817054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10606920 [patent_doc_number] => 09326939 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-03 [patent_title] => 'Liposome targeting compounds and related uses' [patent_app_type] => utility [patent_app_number] => 13/261581 [patent_app_country] => US [patent_app_date] => 2011-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 31 [patent_no_of_words] => 13221 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13261581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8903730 [patent_doc_number] => 20130171233 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-04 [patent_title] => 'COMPOSITIONS AND METHODS FOR INDUCING IMMUNE TOLERANCE' [patent_app_type] => utility [patent_app_number] => 13/261580 [patent_app_country] => US [patent_app_date] => 2011-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8247 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13261580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8228553 [patent_doc_number] => 20120142760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'COMPOSITIONS AND METHODS FOR REGULATED PROTEIN EXPRESSION IN GUT' [patent_app_type] => utility [patent_app_number] => 13/175750 [patent_app_country] => US [patent_app_date] => 2011-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 18660 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13175750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11231251 [patent_doc_number] => 09458473 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-10-04 [patent_title] => 'Compositions and methods for retargeting virus constructs' [patent_app_type] => utility [patent_app_number] => 13/807359 [patent_app_country] => US [patent_app_date] => 2011-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 12153 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13807359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7719823 [patent_doc_number] => 20120009158 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'VENTRICULAR INDUCED PLURIPOTENT STEM (ViPS) CELLS FOR GENERATION OF AUTOLOGOUS VENTRICULAR CARDIOMYOCYTES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/163339 [patent_app_country] => US [patent_app_date] => 2011-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 46282 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20120009158.pdf [firstpage_image] =>[orig_patent_app_number] => 13163339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7777430 [patent_doc_number] => 20120040456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'METHODS OF GENE THERAPY USING NUCLEIC ACID SEQUENCES FOR ATP-BINDING CASSETTE TRANSPORTER' [patent_app_type] => utility [patent_app_number] => 13/151375 [patent_app_country] => US [patent_app_date] => 2011-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 16117 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20120040456.pdf [firstpage_image] =>[orig_patent_app_number] => 13151375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7697011 [patent_doc_number] => 20110229579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'Support Having Nanostructured Titanium Dioxide Film And Uses Thereof' [patent_app_type] => utility [patent_app_number] => 13/117973 [patent_app_country] => US [patent_app_date] => 2011-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3699 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20110229579.pdf [firstpage_image] =>[orig_patent_app_number] => 13117973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8943769 [patent_doc_number] => 08496945 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-30 [patent_title] => 'Nanoparticle delivery systems for membrane-integrating peptides' [patent_app_type] => utility [patent_app_number] => 13/109873 [patent_app_country] => US [patent_app_date] => 2011-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 14 [patent_no_of_words] => 8732 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13109873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9086142 [patent_doc_number] => 08557568 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-15 [patent_title] => 'Method and apparatus for disrupting cells and amplifying nucleic acids using gold nanorods' [patent_app_type] => utility [patent_app_number] => 13/107677 [patent_app_country] => US [patent_app_date] => 2011-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5856 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13107677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7485900 [patent_doc_number] => 20110250643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'ANTIBODY COMPOSITION-PRODUCING CELL' [patent_app_type] => utility [patent_app_number] => 13/102565 [patent_app_country] => US [patent_app_date] => 2011-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 77437 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20110250643.pdf [firstpage_image] =>[orig_patent_app_number] => 13102565 [rel_patent_id] =>[rel_patent_doc_number] =>)